NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today reported operating results for the fiscal first quarter ended October 31, 2011.
Among the quarter’s highlights:
•Total Company revenues increased year over year, despite a challenging environment in the life sciences markets; •Enzo Clinical Labs revenues increased 15% due to greater market penetration
